- Home
- / Lonza Biologics UK
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lonza Biologics UK financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
£246.3 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 163.4M | 183.5M | 246.3M |
| Cost of goods sold | 128.0M | 141.9M | 166.2M |
| Gross profit | 35.4M | 41.6M | 80.1M |
| Gross profit margin, % | 21.7% | 22.7% | 32.5% |
| General and administrative expense | 20.9M | 26.8M | 22.7M |
| Operating expense total | 20.9M | 26.8M | 22.7M |
| EBIT | 17.5M | 19.7M | 59.3M |
| EBIT margin, % | 10.7% | 10.7% | 24.1% |
| Interest income | 3.2M | 3.5M | 3.2M |
| Interest expense | 3.8M | 4.8M | 4.7M |
| Pre tax profit | 16.9M | 18.2M | 57.9M |
| Income tax expense | 3.2M | 12.6M | 5.8M |
| Net Income | 13.7M | 5.6M | 52.1M |